Nova Patents
IL166809A0

Pharmaceutical nati-tnf-alpha antibody formulation

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

138 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
22214002United States of AmericaA
0304502International Bureau of the World Intellectual Property Organization (WIPO)W

Members138

Family members, oldest first
DocumentOfficeKind
US2004033228A1United States of AmericaA1
CA2494756A1CanadaA1
CA2854798A1CanadaA1
CA2872088A1CanadaA1
CA2872089A1CanadaA1
CA2872091A1CanadaA1
CA2882905A1CanadaA1
CA2882907A1CanadaA1
CA2882931A1CanadaA1
CA2882934A1CanadaA1
WO2004016286A2World Intellectual Property Organization (WIPO)A2
AU2003267744A1AustraliaA1
UY27940A1UruguayA1
WO2004016286A3World Intellectual Property Organization (WIPO)A3
PE20040994A1PeruA1
TW200500083ATaiwan Province of ChinaA
AR040881A1ArgentinaA1
EP1528933A2European Patent Office (EPO)A2
KR20050067140ARepublic of KoreaA
BR0313492ABrazilA
MXPA05001841AMexicoA
CN1688339AChinaA
HK1074008AHong Kong, ChinaA
HK1074008A1Hong Kong, ChinaA1
PL375272A1PolandA1
IL166809A0This recordIsraelA0
IL166809D0IsraelD0
ZA200501032BSouth AfricaB
JP2006511457AJapanA
US2006153846A1United States of AmericaA1
NZ538030ANew ZealandA
CN101721702AChinaA
TWI331532BTaiwan Province of ChinaB
CL2010000603A1ChileA1
IL207028A0IsraelA0
IL207028D0IsraelD0
KR20110036870ARepublic of KoreaA
CN102049045AChinaA
CN102078608AChinaA
AR077412A2ArgentinaA2
EP2359856A1European Patent Office (EPO)A1
EP2361637A1European Patent Office (EPO)A1
EP2363144A1European Patent Office (EPO)A1
EP2363145A1European Patent Office (EPO)A1
JP2012046527AJapanA
JP4925582B2JapanB2
EP1528933B1European Patent Office (EPO)B1
CN1688339BChinaB
AT555809TAustriaT
ATE555809T1AustriaT1
PL398596A1PolandA1
US8216583B2United States of AmericaB2
DK1528933T3DenmarkT3
PT1528933EPortugalE
ES2387616T3SpainT3
SI1528933T1SloveniaT1
US2012282270A1United States of AmericaA1
KR20120130258ARepublic of KoreaA
PL212934B1PolandB1
KR101273568B1Republic of KoreaB1
KR101367743B1Republic of KoreaB1
US2014086929A1United States of AmericaA1
US2014086930A1United States of AmericaA1
US2014086931A1United States of AmericaA1
PL406852A1PolandA1
JP2014074034AJapanA
US2014127222A1United States of AmericaA1
CA2494756CCanadaC
KR20140092236ARepublic of KoreaA
US8795670B2United States of AmericaB2
US8802100B2United States of AmericaB2
US8802101B2United States of AmericaB2
US8802102B2United States of AmericaB2
JP5608619B2JapanB2
US2014314781A1United States of AmericaA1
US2014322228A1United States of AmericaA1
PL218221B1PolandB1
US2014341924A1United States of AmericaA1
US2014341925A1United States of AmericaA1
CN101721702BChinaB
US8911741B2United States of AmericaB2
US8916157B2United States of AmericaB2
US8916158B2United States of AmericaB2
US8932591B2United States of AmericaB2
US8940305B2United States of AmericaB2
PL218834B1PolandB1
IL166809AIsraelA
MY153718AMalaysiaA
US2015093394A1United States of AmericaA1
KR101529583B1Republic of KoreaB1
CA2872089CCanadaC
CA2882905CCanadaC
CA2882907CCanadaC
CA2882934CCanadaC
US9114166B2United States of AmericaB2
AU2003267744C1AustraliaC1
US2015306224A1United States of AmericaA1
JP2015199741AJapanA
IL207028AIsraelA
US2015343065A1United States of AmericaA1
Showing 100 of 138